Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer

NCT03774732 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT03774732
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03774732 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer
Lead sponsor
UNICANCER
Phase
Phase 3
Overall status
Active, not recruiting
Start date
January 24, 2018
Completion date
December 22, 2026
Enrollment
327 (estimated)
Sites
58

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer, non small cell lung cancer metastatic, non-small cell carcinoma of lung, tnm stage 4